Paige Dellerman

Our CEO, Christina DiArcangelo is looking forward to speaking tomorrow in Boston, MA at the Arena CLINICAL TRIALS IN ONCOLOGY EAST COAST. Her topic is entitled “Strengthening clinical trial diversity to reduce inequities in cancer trials and delving into the humanitarian aspects of patient care”. The session outline is as follows: • Working with unrepresented communities to help patients globally and sharing best practice how to recruit and integrate these populations into oncology trials • What is your humanitarian responsibility as it relates to clinical trial recruitment? • Meeting FDA expectations: Guidance on the DEPICT Act compliance and how to write, implement and report on Diversity Plans • Working effectively with sites: What strategies CROs, patient advocacy firms and pharmaceutical companies can design and support to encourage sites to implement these for a diverse patient population • Educating patients to reduce fear and knowing what to ask for from your doctor regarding off label usage and black box warnings from the patient advocacy perspective https://lnkd.in/eTfB_Mp4

2

We are pleased to have our work presented at the Cardiometabolic Health Congress taking place this week in Boston!   Our collaboration with Ionis Pharmaceuticals and key opinion leaders will be showcased in a poster titled "Prevalence, Incidence, and Definition of Severe Hypertriglyceridemia: A Comprehensive Review and Weighted Summary."   This presentation offers valuable insights into the prevalence and incidence of severe hypertriglyceridemia (sHTG) across diverse populations, providing a clearer understanding of its impact and the variations in clinical guidelines worldwide. https://lnkd.in/gyRaFx8F

10

Good Morning from New Jersey! It's Day One at the Nexus Conference - 21st BioPharma Clinical Trials! What a fantastic opportunity to connect with leaders and innovators in the world of clinical trials. Today, we are excited to participate in the Panel Discussion on Running Clinical Trials in Different Geographic Regions: Assessing Opportunities and Challenges, featuring Rui Rui Zhang Xiang Business Director. Stay tuned for insights and key takeaways on overcoming the complexities of global trials! #ClinicalTrials #Biopharma #PharmaInnovation

60

We are excited to sponsor and exhibit at the 2024 International Congress of Parkinson’s Disease and Movement Disorders that starts this Friday in Philadelphia, PA. In addition to showcasing our products for digital data collection in clinical trials and research (Booth # 304), our team and collaborators will be presenting the following 4 posters at the meeting: 1) Speech Analysis and Machine Learning can Aid in Identifying Different Neurological Disorders    2) Remote Monitoring of Upper Limb Function in Huntington’s Disease Using a Wearable Sensor   3) Remote Digital Longitudinal Assessment of Speech, Fluency and Cognitive Function in Progressive Supranuclear Palsy    4) Predicting Disease Severity in Friedreich's Ataxia through Wearable Monitoring and Machine Learning #RareDisease #NeurodegenerativeDisease #neurology #digitalhealth #clinicaltrials CurePSP Friedreich's Ataxia Research Alliance (FARA) National Ataxia Foundation The Association for Frontotemporal Degeneration (AFTD) Huntington's Disease Society of America American Academy of Neurology International Parkinson and Movement Disorder Society

16

1 Comment

How can the patient voice help clinical research? From offering solutions for the industry to raising awareness of participation barriers, patients, caregivers, and advocates can provide invaluable insights for your drug development program. Make sure to attend Aman Khera EMBA FRAPS FTOPRA’s forum at DIA this year to learn more!

68

4 Comments